Yash Optics & Lens Ltd(YASHOPTICS)

NSE: YASHOPTICS

₹ 117-1.68%refreshed 23 Oct, 03:30 pm ISTMarket cap: ₹ 290 crUpdated: 26 Oct 2026

About

Yash Optics & Lens Ltd makes and distributes ophthalmic lenses, including progressive lenses, from a facility in Mumbai and a lens casting facility in Vapi, Gujarat. It reported FY26 revenue of Rs 53.99 Cr. As of FY26 it reaches more than 10,500 retail stores. Under an agreement with HOYA, it is the exclusive India distributor for Pentax ophthalmic lenses.^[1][2][3]

Products and brands

Progressive lenses made up 65.80% of revenue in H1 FY25, up from 64.42% earlier.^[4]
Under its agreement with HOYA, the company is the exclusive distributor of Pentax ophthalmic lenses in India (FY25).^[3]
Management plans to build up its own brands and to expand hospital counters and supply to OEMs and organised retail (FY26).^[2]

Manufacturing and capacity

The Mumbai facility can produce more than 2,400 lens pairs per day and ran at 70% utilisation in FY26.^[2]
The Vapi, Gujarat facility covers 36,000 sq ft and started production in 2026. It can make about 10,000 lens pairs per day.^[2]
About 20% of Vapi's output is used in-house. The rest is sold to other businesses in India.^[2]
Utilisation by process in H1 FY25: ARC coating 63%, hard coat 50% and digital surfacing 76%.^[4]

Key operating numbers

Gross margin was 66.9% in FY26, compared with 65.8% in FY25.^[2]
Gross margin was 69.1% in H2 FY26, down from 80.9% in H2 FY25, as raw material costs doubled.^[2]

Customers and distribution

The company reached more than 10,500 retail stores in FY26, up from more than 7,000 partner stores reported in Q2 FY25.^[2][4]
Exports were 8% of revenue in FY26, down from 12% in FY25.^[2]
FY25 exports were Rs 532.14 lakh on an FOB basis.^[3]
Management plans to focus distribution growth on North and East India (FY26).^[2]

Expansion plans

Vapi capacity can be raised from about 10,000 to 20,000 pairs per day with lower additional capex, depending on demand.^[2]
The Vapi plant is meant to replace imports, and the roughly 20% used in-house is expected to help margins.^[2]
Management plans to grow operations across India and look at international markets (FY26 annual report).^[5]
IPO proceeds were earmarked to expand progressive lens capacity at existing premises and upgrade technology (FY25).^[3]

Recent developments

On 15 Oct 2026 the company reported a cyber-attack on its IT systems. Affected systems were shut down and cybersecurity experts were brought in to investigate.^[6]
Debt to equity fell to 0.05 in FY26 from 0.16, and long-term borrowings dropped from Rs 1,231 lakh to Rs 450 lakh.^[2]

Market Cap

₹290 Cr

High / Low

₹142 / 98

Stock P/E

33.1

Price / Book

3.2

Book Value

₹40

EPS

₹3.6

No. of Shares

2.48 Cr

ROCE

12.8%

ROE

9.5%

OPM

24.3%

Debt / Equity

0.05

Sales

₹54 Cr

Net Profit

₹9 Cr

Promoter holding

73.3%

Loading chart…

Signal history

AI Deep Dive

The analysis Screener can't give you

Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:

Verdict
The headline call - descriptive label, conviction, and the synthesis behind it.
Valuation
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Walk the talk
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Red flags
Forensic and governance risk pointers, severity-ranked.
Balance sheet
Solvency and earnings-quality score.
Concall briefs
Quarter-by-quarter earnings-call briefs - what changed and why.

₹49 unlocks this company for 90 days, ₹299 for a full year - bundles bring it lower. Built on public disclosures - educational, not investment advice.

AI Deep Dive

Verdict

Locked

The headline call - descriptive label, conviction, and the synthesis behind it.

Company data

Financials